EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

IST-ECILC
Istanbul Stock Exchange NYSE
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#10540
Country Rank
n/a
Market Cap
815.23 M
Price
1.17
Change (%)
1.84%
Volume
3.98 M

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s latest marketcap:

815.23 M

As of 06/05/2025, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s market capitalization has reached $815.23 M. According to our data, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is the 10540th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 815.23 M
Revenue (ttm) 200.19 M
Net Income (ttm) 48.36 M
Shares Out 685.26 M
EPS (ttm) 0.07
Forward PE 0.00
Ex-Dividend Date 05/14/2025
Earnings Date 08/05/2025
Market Cap Chart
Data Updated: 06/05/2025

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s yearly market capitalization.

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. has seen its market value grow from ₺5.11 B to ₺32.7 B since 2020, representing a total increase of 539.68% and an annual compound growth rate (CAGR) of 52.07%.
Date Market Cap Change (%)
06/05/2025 ₺32.7 B 0.25%
12/31/2024 ₺32.62 B 8.28%
12/29/2023 ₺30.12 B 36.44%
12/30/2022 ₺22.08 B 330.17%
12/31/2021 ₺5.13 B 0.4%
12/31/2020 ₺5.11 B

Company Profile

About EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

EIS Eczacibasi Ilaç operates in the health and real estate sectors, serving both Turkey and international markets. The company is a subsidiary of Eczacibasi Holding A.S. and was established in 1951, with its headquarters in Istanbul, Turkey.

Business Segments

  • Health Segment:

    Produces and sells pharmaceuticals for human and veterinary use, along with sales and marketing services in the pharmaceutical industry.

  • Real Estate Development Segment:

    Engages in property development, leasing of serum facilities, and provides consulting services for land development and project management.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.